Viktoria Zieger and her startup sfir
Today, we’re launching our new video format, “Cluster Stories”: Who are the people and stories behind all the research and application development driven forward within the nanodiag BW network?
To kick things off, we’re thrilled to introduce Viktoria Zieger and the startup sfir! Viktoria is on the verge of completing her PhD at the Department of Microsystems Engineering at the University of Freiburg and brings years of experience in 3D cell culture. Together with scientists, engineers, and software developers from IMTEK at the University of Freiburg and the Hahn-Schickard Institute, she has developed an innovative platform for 3D cell culture that enables more efficient use of organoids in drug development. With this idea, sfir is now embarking on an exciting future!
What are organoids?
Organoids are miniature organs cultivated in the lab that simulate real organs within the human body. They offer a promising approach for developing new therapies and researching diseases.
With sfir, Viktoria is applying her expertise in laboratory automation to make organoid handling more efficient and reliable. This technology aims to play a crucial role in accelerating drug research and reducing the need for animal testing.
